Literature DB >> 15834876

Oligonucleotide array for simultaneous detection of respiratory viruses using a reverse-line blot hybridization assay.

M T Coiras1, M R López-Huertas, G López-Campos, J C Aguilar, P Pérez-Breña.   

Abstract

The interest in developing new diagnostic methods based on arrays of multiple probes to detect and type simultaneously a wide range of different infectious agents is increasing. This becomes a necessity in the case of infectious agents such as respiratory viruses that cause diseases with very similar signs and symptoms. Such tools will permit rapid and accurate diagnosis of different agents causing respiratory infection leading to the most adequate prevention and/or treatment measures. In this article a reverse-line blot hybridization (RLB) assay for the detection of a wide range of respiratory viruses is presented and evaluated for its usefulness in routine diagnosis. This assay employs an array of 18 oligonucleotide probes immobilized on a nylon membrane. Biotin-labeled PCR products obtained with two multiplex reverse transcription (RT)-polymerase chain reaction (PCR) assays described previously, which allow for the detection of fourteen different groups of respiratory viruses, were hybridized to the oligonucleotide array. Detection was performed using a chemiluminescent method. The standardization of the method showed that the RLB assay could be an alternative to the nested PCR assay for enhancing the sensitivity in the detection of the amplified products, avoiding the problem of cross-over contamination, increasing the specificity, and therefore simplifying the method. This is of main interest in laboratories with few facilities. The feasibility and accuracy of the RT-PCR-RLB assay for detecting respiratory viruses proves that such approach could be a first stage to develop a microarray assay for routine diagnosis of infectious diseases. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834876      PMCID: PMC7159148          DOI: 10.1002/jmv.20350

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Simultaneous detection and genotyping of "Norwalk-like viruses" by oligonucleotide array in a reverse line blot hybridization format.

Authors:  J Vinjé; M P Koopmans
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.

Authors:  L Liolios; A Jenney; D Spelman; T Kotsimbos; M Catton; S Wesselingh
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay.

Authors:  I Casas; L Powell; P E Klapper; G M Cleator
Journal:  J Virol Methods       Date:  1995-05       Impact factor: 2.014

4.  Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes.

Authors:  A Kaufhold; A Podbielski; G Baumgarten; M Blokpoel; J Top; L Schouls
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

5.  Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay.

Authors:  M T Coiras; P Pérez-Breña; M L García; I Casas
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

6.  Rapid and sensitive diagnosis of human adenovirus infections by a generic polymerase chain reaction.

Authors:  A Avellón; P Pérez; J C Aguilar; R Lejarazu; J E Echevarría
Journal:  J Virol Methods       Date:  2001-04       Impact factor: 2.014

7.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines.

Authors:  A Hopert; C C Uphoff; M Wirth; H Hauser; H G Drexler
Journal:  J Immunol Methods       Date:  1993-08-26       Impact factor: 2.303

Review 9.  Recent advances in the rapid diagnosis of respiratory tract infection.

Authors:  Steven Myint
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

10.  Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays.

Authors:  M T Coiras; J C Aguilar; M L García; I Casas; P Pérez-Breña
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

View more
  16 in total

1.  Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions.

Authors:  Desmond W Cox; Joelene Bizzintino; Giovanni Ferrari; Siew Kim Khoo; Guicheng Zhang; Siobhan Whelan; Wai Ming Lee; Yury A Bochkov; Gary C Geelhoed; Jack Goldblatt; James E Gern; Ingrid A Laing; Peter N Le Souëf
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

2.  Using a resequencing microarray as a multiple respiratory pathogen detection assay.

Authors:  Baochuan Lin; Kate M Blaney; Anthony P Malanoski; Adam G Ligler; Joel M Schnur; David Metzgar; Kevin L Russell; David A Stenger
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

3.  Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting.

Authors:  David J Marshall; Erik Reisdorf; Gerda Harms; Edward Beaty; Michael J Moser; Wai-Ming Lee; James E Gern; Frederick S Nolte; Pete Shult; James R Prudent
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

4.  Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems.

Authors:  Fanny Renois; Déborah Talmud; Antoine Huguenin; Lauryane Moutte; Christophe Strady; Joel Cousson; Nicolas Lévêque; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

5.  High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses.

Authors:  Wai-Ming Lee; Kris Grindle; Tressa Pappas; David J Marshall; Michael J Moser; Edward L Beaty; Peter A Shult; James R Prudent; James E Gern
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

6.  Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children.

Authors:  Frédéric Raymond; Julie Carbonneau; Nancy Boucher; Lynda Robitaille; Sébastien Boisvert; Whei-Kuo Wu; Gaston De Serres; Guy Boivin; Jacques Corbeil
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

Review 7.  Use and evaluation of molecular diagnostics for pneumonia etiology studies.

Authors:  Niranjan Bhat; Katherine L O'Brien; Ruth A Karron; Amanda J Driscoll; David R Murdoch
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

8.  Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates.

Authors:  María Rosa López-Huertas; Inmaculada Casas; Belsy Acosta-Herrera; María Luz García; María Teresa Coiras; Pilar Pérez-Breña
Journal:  J Virol Methods       Date:  2005-10       Impact factor: 2.014

9.  Application of molecular diagnostic techniques for viral testing.

Authors:  Fernando Cobo
Journal:  Open Virol J       Date:  2012-11-30

Review 10.  Nucleic acid amplification tests for detection of respiratory viruses.

Authors:  Julie D Fox
Journal:  J Clin Virol       Date:  2007-11       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.